YATHARTH

🏥 Expansion & Operations

📈 Financial Performance The company reported strong growth with June 2025 quarter revenues rising by more than 20% year-on-year. Its stock has shown sharp momentum, gaining over 50% in the last three months and recently touching an all-time high. The company has also been added to the MSCI India Small Cap Index, increasing visibility among global investors. 🏥 Expansion & Operations Yatharth signed a deal to acquire Shantived Hospital in Agra for around ₹260 crore, expanding its presence in Uttar Pradesh. A new super-specialty hospital was launched in Model Town, New Delhi, further strengthening its footprint in the NCR region. The company has invested in advanced treatments, including successfully performing CAR-T cell therapy at its Noida Extension hospital. It has become the first hospital in Uttar Pradesh to secure JCI accreditation, highlighting its focus on global healthcare standards. The group has expanded capacity in Faridabad through hospital acquisitions and bed additions. 🧾 Corporate & Governance A new Group Chief for Strategy, M&A, and Investor Relations has been appointed to lead growth and expansion. Notable investor interest has been seen, with ace investors increasing their stake in the company recently. Regular updates on governance, sustainability, and analyst interactions have been disclosed, showing transparency and regulatory compliance.